Wells Fargo lowered the firm’s price target on Bill (BILL) to $57 from $65 and keeps an Underweight rating on the shares. Ahead of the print, the firm was skeptical, and believed that unproven elements of the long-term thesis were being overlooked, most importantly, take rate. These concerns manifested in a Q3 guide down despite improving SMB optimism, Wells adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BILL: